Wei Li is the founder of CytoLynx Therapeutics. CytoLynx Therapeutics has raised $45M in total funding. Latest round: Series A.
Dr. Wei Li is a biopharmaceutical researcher and executive. He serves as Chief Scientific Officer at Cytovia Therapeutics, a company focused on gene-edited NK cell therapies. He was involved in the formation of CytoLynx Therapeutics, a China-focused joint venture of Cytovia.
Full founder directory · Investor directory · Company funding database · Fundraising library